Mersana Therapeutics
MRSN
MRSN
135 hedge funds and large institutions have $1.28B invested in Mersana Therapeutics in 2020 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 55 increasing their positions, 37 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.1% more ownership
Funds ownership: 3.91% → 4.02% (+0.1%)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
17% less capital invested
Capital invested by funds: $1.53B → $1.28B (-$256M)
Holders
135
Holding in Top 10
8
Calls
$8.8M
Puts
$2.97M
Top Buyers
| 1 | +$28.9M | |
| 2 | +$25.7M | |
| 3 | +$20.2M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$19.4M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$16.8M |
Top Sellers
| 1 | -$45.2M | |
| 2 | -$37.2M | |
| 3 | -$14.7M | |
| 4 |
O
OrbiMed
New York
|
-$10.8M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$7.02M |